当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
标题(英文)
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
条件
Extensive-stage Small Cell Lung Cancer
干预
Drug: Atezolizumab 1200 mg in 20 ML Injection|Biological: ADC Vaccine|Drug: Carboplatin